Bear Mountain Capital, Inc. Mirum Pharmaceuticals, Inc. Transaction History
Bear Mountain Capital, Inc.
- $246 Billion
- Q2 2024
Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
179Shares Held
54.3MCall Options Held
85KPut Options Held
59.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$281 Million8.57% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$189 Million3.29% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.3MShares$143 Million1.34% of portfolio
-
State Street Corp Boston, MA2.82MShares$122 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X02.77MShares$120 Million0.04% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.59B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...